In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal

American Journal of Tropical Medicine and Hygiene

Volumn 66, Issue 5, 2002, Pages 474-480

  Thomas, Susan M ^a   Ndir, Omar ^a   Dieng, Therese ^a   Mboup, Souleymane ^a   Wypij, David ^a   Maguire, James H ^a   Wirth, Dyann F ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHLOROQUINE; GENE PRODUCT; PROTEIN PFCRT; PROTEIN PFMDR1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELISM; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; PARASITE PREVALENCE; POLYMERASE CHAIN REACTION; PREDICTION; SENEGAL;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036562621     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.66.474     Document Type: Article

References (39)

1. Impact of chloroquine resistance on malaria mortality
2. Chloroquine-resistant Plasmodium falciparum malaria in Senegal
3. A case of chloroquine-resistant malaria in Senegal
4. In vivo chemosensitivity tests of Plasmodium falciparum to chloroquine in Senegal: The development of resistance and the assessment of therapeutic efficacy
5. Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates
6. Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique
7. Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance
8. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites
9. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance
10. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates
11. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum
12. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum
13. Chloroquine: Mechanism of drug action and resistance in Plasmodium falciparum
14. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: An ordered process in a unique organelle
15. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
16. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum
17. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine
18. Guinea Bissau: Association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistance gene pfmdr1
19. Two mutations in the multidrug-resistance gene homologue of Plasmodium falciparum, pfmdr1, are not useful predictors of in-vivo or in-vitro chloroquine resistance in southern Africa
20. Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance
21. Pfmdr1 Asn1042Asp and Asp1246Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum
22. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
23. A molecular marker for chloroquine-resistant falciparum malaria
24. Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaounde, Cameroon
25. Plasmodium falciparum malaria in Laos: Chloroquine treatment out-come and predictive value of molecular markers
26. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine-resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1
27. Severe and complicated malaria
28. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH)
29. In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs
30. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil
31. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand
32. Rapid detection of pfmdr1 mutations in chloroquine-resistant Plasmodium falciparum malaria by polymerase chain reaction analysis of blood spots
33. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique
34. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum
35. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda
36. Molecular approaches to the spreading problem of drug resistant malaria
37. Plasmodium falciparum: In vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon
38. Correlation of in vivo-resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda
39. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: Evidence for quinine resistance